SCHEMBL1264052

SCHEMBL1264052

CC(C)c1cc(C(=O)c2ccccc2)c(O)c(-n2nc3ccccc3n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 3/20 0.49
MCL1 Q07820 3/20 0.49
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
POLB P06746 1/20 0.41
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 5/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
PTGS1 P23219 2/20 0.36
CXCR1 P25024 2/20 0.36
CXCR2 P25025 2/20 0.36
PTGS2 P35354 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1263997 0.83 NPC1 (0.58) BCL2MCL1NPC1RAB9APOLB
SCHEMBL1263980 0.80 NPC1 (0.42) BCL2MCL1NPC1RAB9APOLB
SCHEMBL1264286 0.80 BCL2 (0.37) BCL2MCL1NPC1RAB9APOLB
SCHEMBL9418498 0.79 NPC1 (0.43) BCL2MCL1NPC1RAB9APOLB
SCHEMBL4357048 0.78 NPC1 (0.50) BCL2MCL1GABRA1GABRB1NPC1
SCHEMBL1263991 0.78 NPC1 (0.40) BCL2MCL1NPC1RAB9APOLB
SCHEMBL20363907 0.78 NPC1 (0.47) GABRA1NPC1RAB9APOLBALDH1A1
SCHEMBL9467622 0.77 NPC1 (0.52) GABRA1NPC1RAB9APOLBALDH1A1
SCHEMBL26658010 0.76 NPC1 (0.46) BCL2MCL1GABRA1NPC1RAB9A
SCHEMBL14324336 0.76 IDH1 (0.44) BCL2NPC1RAB9APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332013-A1 ULTRAVIOLET LIGHT ABSORBING KETONES OF 2-(2-HYDROXYPHENYL) BENZOTRIAZOLE Chang, Chia-Hu (US) 2011-06-15 EP claimed
US-7847103-B2 Ultraviolet light absorbing ketones of 2-(2-hydroxyphenyl) benzotriazole CHANG CHIA-HU 2010-12-07 US claimed
US-20100086500-A1 Ultraviolet light absorbing ketones of 2-(2-Hydroxyphenyl) benzotriazole CHANG CHIA-HU 2010-04-08 US claimed
WO-2010039229-A1 ULTRAVIOLET LIGHT ABSORBING KETONES OF 2-(2-HYDROXYPHENYL) BENZOTRIAZOLE CHANG CHIA-HU (US) 2010-04-08 WO claimed
US-8163934-B2 Ultraviolet light absorbing ketones of 2-(2-hydroxyphenyl) benzotriazole CHANG CHIA-HU (US) 2012-04-24 US disclosed
EP-2332013-A1 ULTRAVIOLET LIGHT ABSORBING KETONES OF 2-(2-HYDROXYPHENYL) BENZOTRIAZOLE Chang, Chia-Hu (US) 2011-06-15 EP disclosed
US-20110038816-A1 Ultraviolet light absorbing ketones of 2-(2-hydroxyhenyl) benzotriazole CHANG CHIA-HU 2011-02-17 US disclosed
US-7847103-B2 Ultraviolet light absorbing ketones of 2-(2-hydroxyphenyl) benzotriazole CHANG CHIA-HU 2010-12-07 US disclosed
US-20100086500-A1 Ultraviolet light absorbing ketones of 2-(2-Hydroxyphenyl) benzotriazole CHANG CHIA-HU 2010-04-08 US disclosed
WO-2010039229-A1 ULTRAVIOLET LIGHT ABSORBING KETONES OF 2-(2-HYDROXYPHENYL) BENZOTRIAZOLE CHANG CHIA-HU (US) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110038816-A1 Ultraviolet light absorbing ketones of 2-(2-hydroxyhenyl) benzotriazole HCRTR2, HCRTR1, POLL BCL2 371/4885MCL1 3341/4885GABRA1 91/4885
US-20100086500-A1 Ultraviolet light absorbing ketones of 2-(2-Hydroxyphenyl) benzotriazole HCRTR2, HCRTR1, PAH BCL2 401/4885MCL1 3466/4885GABRA1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.